{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:44:08Z","timestamp":1788039848887,"version":"build-2784847793"},"reference-count":132,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background and Aims: Lynch syndrome (LS) is currently one of the most prevalent hereditary cancer conditions, accounting for 3% of all colorectal cancers and for up to 15% of those with DNA mismatch repair (MMR) deficiency, and it was one of the first historically identified. The understanding of the molecular carcinogenesis of LS tumors has progressed significantly in recent years. We aim to review the most recent advances in LS research and explore genotype-based approaches in surveillance, personalized cancer prevention, and treatment strategies. Methods: PubMed was searched to identify relevant studies, conducted up to December 2023, investigating molecular carcinogenesis in LS, surveillance strategies, cancer prevention, and treatment in LS tumors. Results: Multigene panel sequencing is becoming the benchmark in the diagnosis of LS, allowing for the detection of a pathogenic constitutional variant in one of the MMR genes. Emerging data from randomized controlled trials suggest possible preventive roles of resistant starch and\/or aspirin in LS. Vaccination with immunogenic frameshift peptides appears to be a promising approach for both the treatment and prevention of LS-associated cancers, as evidenced by pre-clinical and preliminary phase 1\/2a studies. Conclusions: Although robust diagnostic algorithms, including prompt testing of tumor tissue for MMR defects and referral for genetic counselling, currently exist for suspected LS in CRC patients, the indications for LS screening in cancer-free individuals still need to be refined and standardized. Investigation into additional genetic and non-genetic factors that may explain residual rates of interval cancers, even in properly screened populations, would allow for more tailored preventive strategies.<\/jats:p>","DOI":"10.3390\/cancers16050849","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:50:07Z","timestamp":1708429807000},"page":"849","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lynch Syndrome: From Multidisciplinary Management to Precision Prevention"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-4355","authenticated-orcid":false,"given":"Arianna","family":"Dal Buono","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-4043","authenticated-orcid":false,"given":"Alberto","family":"Puccini","sequence":"additional","affiliation":[{"name":"Medical Oncology and Haematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-4981","authenticated-orcid":false,"given":"Gianluca","family":"Franchellucci","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Airoldi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bartolini","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-5644","authenticated-orcid":false,"given":"Paolo","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Clinical Analysis Laboratory, Oncological Molecular Genetics Section, IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[{"name":"Medical Oncology and Haematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Repici","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3878","article-title":"Milestones of Lynch Syndrome: 1895\u20132015","volume":"15","author":"Lynch","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch Syndrome Genetics and Clinical Implications","volume":"164","author":"Mecklin","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","article-title":"Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer","volume":"26","author":"Win","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer Susceptibility Gene Mutations in Individuals with Colorectal Cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/modpathol.2016.135","article-title":"Germline Multi-Gene Hereditary Cancer Panel Testing in an Unselected Endometrial Cancer Cohort","volume":"29","author":"Ring","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer Risk and Survival in Path_MMR Carriers by Gene and Gender up to 75 Years of Age: A Report from the Prospective Lynch Syndrome Database","volume":"67","author":"Bernstein","year":"2018","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/genes5030497","article-title":"Lynch Syndrome: An Updated Review","volume":"5","author":"Sehgal","year":"2014","journal-title":"Genes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.soc.2021.11.010","article-title":"Management of Colorectal Cancer in Hereditary Syndromes","volume":"31","author":"Cunningham","year":"2022","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","article-title":"Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer","volume":"109","author":"Giardiello","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","article-title":"The Human Mutator Gene Homolog MSH2 and Its Association with Hereditary Nonpolyposis Colon Cancer","volume":"75","author":"Fishel","year":"1993","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13053-023-00263-3","article-title":"Dominantly Inherited Micro-Satellite Instable Cancer\u2014The Four Lynch Syndromes\u2014An EHTG, PLSD Position Statement","volume":"21","author":"Ahadova","year":"2023","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMoa053493","article-title":"Identification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon Cancer","volume":"354","author":"Barnetson","year":"2006","journal-title":"New Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/5.Supplement_1.1489","article-title":"Mismatch Repair Defects in Human Carcinogenesis","volume":"5","author":"Eshleman","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2009.068122","article-title":"Constitutional (Germline) MLH1 Epimutation as an Aetiological Mechanism for Hereditary Non-Polyposis Colorectal Cancer","volume":"46","author":"Hitchins","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ng1866","article-title":"Heritable Germline Epimutation of MSH2 in a Family with Hereditary Nonpolyposis Colorectal Cancer","volume":"38","author":"Chan","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ng.283","article-title":"Heritable Somatic Methylation and Inactivation of MSH2 in Families with Lynch Syndrome Due to Deletion of the 3\u2032 Exons of TACSTD1","volume":"41","author":"Ligtenberg","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)65048-1","article-title":"Genetic and Epigenetic Modification of MLH1 Accounts for a Major Share of Microsatellite-Unstable Colorectal Cancers","volume":"156","author":"Kuismanen","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1158\/0008-5472.CAN-07-0869","article-title":"Epigenetic Inactivation of a Cluster of Genes Flanking MLH1 in Microsatellite-Unstable Colorectal Cancer","volume":"67","author":"Hitchins","year":"2007","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2013.200","article-title":"The MLH1 c.-27C>A and c.85G>T Variants Are Linked to Dominantly Inherited MLH1 Epimutation and Are Borne on a European Ancestral Haplotype","volume":"22","author":"Kwok","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10689-012-9544-4","article-title":"Clinical Correlation and Molecular Evaluation Confirm That the MLH1 p.Arg182Gly (c.544A>G) Mutation Is Pathogenic and Causes Lynch Syndrome","volume":"11","author":"Farrell","year":"2012","journal-title":"Fam. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2005.12.033","article-title":"New Founding Mutation in MSH2 Associated with Hereditary Nonpolyposis Colorectal Cancer Syndrome on the Island of Tenerife","volume":"244","author":"Barrios","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ng.2854","article-title":"Application of a 5-Tiered Scheme for Standardized Classification of 2,360 Unique Mismatch Repair Gene Variants in the InSiGHT Locus-Specific Database","volume":"46","author":"Thompson","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/a-1016-4977","article-title":"Endoscopic Management of Lynch Syndrome and of Familial Risk of Colorectal Cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"51","author":"Roos","year":"2019","journal-title":"Endoscopy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","article-title":"Hereditary Factors in Cancer: Study of Two Large Midwestern Kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch. Intern. Med."},{"key":"ref_25","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cgh.2006.01.002","article-title":"Cancer Risks for Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family Study","volume":"4","author":"Jenkins","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jmg.2004.024299","article-title":"Risk of Colorectal and Endometrial Cancer for Carriers of Mutations of the hMLH1 and hMSH2 Gene: Correction for Ascertainment","volume":"42","author":"Quehenberger","year":"2005","journal-title":"J. Med. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer Risk in Mutation Carriers of DNA-Mismatch-Repair Genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2001.19.20.4074","article-title":"MSH2 Mutation Carriers Are at Higher Risk of Cancer Than MLH1 Mutation Carriers: A Study of Hereditary Nonpolyposis Colorectal Cancer Families","volume":"19","author":"Vasen","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","article-title":"Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease","volume":"338","author":"Aaltonen","year":"1998","journal-title":"New Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer Risks Associated with Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of Risk of Colorectal and Endometrial Cancer among Patients with Lynch Syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1897-4287-7-14","article-title":"Penetrance of Colorectal Cancer among MLH1\/MSH2 Carriers Participating in the Colorectal Cancer Familial Registry in Ontario","volume":"7","author":"Choi","year":"2009","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.ejhg.5201843","article-title":"Estimating Cancer Risk in HNPCC by the GRL Method","volume":"15","author":"Alarcon","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer Risk Associated with Germline DNA Mismatch Repair Gene Mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","article-title":"The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations","volume":"135","author":"Senter","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer Incidence and Survival in Lynch Syndrome Patients Receiving Colonoscopic and Gynaecological Surveillance: First Report from the Prospective Lynch Syndrome Database","volume":"66","author":"Bernstein","year":"2017","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1200\/JCO.2004.02.033","article-title":"Lower Incidence of Colorectal Cancer and Later Age of Disease Onset in 27 Families with Pathogenic MSH6 Germline Mutations Compared with Families with MLH1 or MSH2 Mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium","volume":"22","author":"Plaschke","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMcp1714533","article-title":"Lynch Syndrome\u2013Associated Colorectal Cancer","volume":"379","author":"Sinicrope","year":"2018","journal-title":"New Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02235755","article-title":"Colorectal and Extracolonic Cancer Variations in MLH1\/MSH2 Hereditary Nonpolyposis Colorectal Cancer Kindreds and the General Population","volume":"41","author":"Lin","year":"1998","journal-title":"Dis. Colon. Rectum"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/tog.12706","article-title":"Lynch Syndrome for the Gynaecologist","volume":"23","author":"Ryan","year":"2021","journal-title":"Obstet. Gynaecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/gim.2017.254","article-title":"MSH6 and PMS2 Germ-Line Pathogenic Variants Implicated in Lynch Syndrome Are Associated with Breast Cancer","volume":"20","author":"Roberts","year":"2018","journal-title":"Genet. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Vietri, M.T., D\u2019Elia, G., Caliendo, G., Albanese, L., Signoriello, G., Napoli, C., and Molinari, A.M. (2022). Pancreatic Cancer with Mutation in BRCA1\/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes, 13.","DOI":"10.3390\/genes13020321"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"103178","DOI":"10.1016\/j.dnarep.2021.103178","article-title":"Tissue-Specific Reduction in MLH1 Expression Induces Microsatellite Instability in Intestine of Mlh1+\/\u2212 Mice","volume":"106","author":"Shrestha","year":"2021","journal-title":"DNA Repair."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and Cancer: Statistical Study of Retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/emboj\/cdg216","article-title":"Methylation-Induced G(2)\/M Arrest Requires a Full Complement of the Mismatch Repair Protein hMLH1","volume":"22","author":"Cejka","year":"2003","journal-title":"EMBO J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/carcin\/bgy056","article-title":"MLH1 Deficiency in Normal Mouse Colon Mucosa Associates with Chromosomally Unstable Colon Cancer","volume":"39","author":"Pussila","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1470-2045(12)70109-2","article-title":"Prevalence of Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome: A Pathological Study","volume":"13","author":"Kloor","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41379-018-0044-4","article-title":"Molecular Changes Preceding Endometrial and Ovarian Cancer: A Study of Consecutive Endometrial Specimens from Lynch Syndrome Surveillance","volume":"31","author":"Niskakoski","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41379-020-0455-x","article-title":"Frequent Loss of Mutation-Specific Mismatch Repair Protein Expression in Nonneoplastic Endometrium of Lynch Syndrome Patients","volume":"33","author":"Wong","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41467-022-29920-2","article-title":"Mutational Landscape of Normal Epithelial Cells in Lynch Syndrome Patients","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ijc.33224","article-title":"The \u201cUnnatural\u201d History of Colorectal Cancer in Lynch Syndrome: Lessons from Colonoscopy Surveillance","volume":"148","author":"Ahadova","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1940-6207.CAPR-11-0519","article-title":"Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps","volume":"5","author":"Yurgelun","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1053\/j.gastro.2019.12.032","article-title":"Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients with Lynch Syndrome","volume":"158","author":"Engel","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ahadova, A., Pfuderer, P.L., Ahtiainen, M., Ballhausen, A., Bohaumilitzky, L., K\u00f6segi, S., M\u00fcller, N., Tang, Y.L., Kosmalla, K., and Witt, J. (2021). Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112458"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10689-016-9899-z","article-title":"CTNNB1-Mutant Colorectal Carcinomas with Immediate Invasive Growth: A Model of Interval Cancers in Lynch Syndrome","volume":"15","author":"Ahadova","year":"2016","journal-title":"Fam. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.gastro.2018.05.020","article-title":"Molecular Background of Colorectal Tumors from Patients with Lynch Syndrome Associated with Germline Variants in PMS2","volume":"155","author":"Jansen","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"103338","DOI":"10.1016\/j.critrevonc.2021.103338","article-title":"The Diverse Molecular Profiles of Lynch Syndrome-Associated Colorectal Cancers Are (Highly) Dependent on Underlying Germline Mismatch Repair Mutations","volume":"163","author":"Helderman","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"New Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","article-title":"Cancer Prevention with Aspirin in Hereditary Colorectal Cancer (Lynch Syndrome), 10-Year Follow-up and Registry-Based 20-Year Data in the CAPP2 Study: A Double-Blind, Randomised, Placebo-Controlled Trial","volume":"395","author":"Burn","year":"2020","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/gutjnl-2020-320946","article-title":"Naproxen Chemoprevention Promotes Immune Activation in Lynch Syndrome Colorectal Mucosa","volume":"70","author":"Wu","year":"2021","journal-title":"Gut"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.gastro.2021.11.029","article-title":"The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients","volume":"162","author":"Bohaumilitzky","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1038\/s41467-020-18514-5","article-title":"The Shared Frameshift Mutation Landscape of Microsatellite-Unstable Cancers Suggests Immunoediting during Tumor Evolution","volume":"11","author":"Ballhausen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.5139","article-title":"Lynch Syndrome\u2014Cancer Pathways, Heterogeneity and Immune Escape","volume":"246","author":"Seth","year":"2018","journal-title":"J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/path.5422","article-title":"Molecular Pathology of Lynch Syndrome","volume":"250","author":"Cerretelli","year":"2020","journal-title":"J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Guidelines for the Management of Hereditary Colorectal Cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG)","volume":"69","author":"Monahan","year":"2020","journal-title":"Gut"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.38606.794560.EB","article-title":"Prevention of Colorectal Cancer by Colonoscopic Surveillance in Individuals with a Family History of Colorectal Cancer: 16 Year, Prospective, Follow-up Study","volume":"331","author":"Sasieni","year":"2005","journal-title":"BMJ"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","article-title":"One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome","volume":"138","author":"Vasen","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","article-title":"The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?","volume":"4","author":"Hampel","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10689-013-9685-0","article-title":"Comparison of Attitudes Regarding Preimplantation Genetic Diagnosis among Patients with Hereditary Cancer Syndromes","volume":"13","author":"Rich","year":"2014","journal-title":"Fam. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":"A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines","volume":"89","author":"Boland","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jmg.2010.077677","article-title":"Current Clinical Criteria for Lynch Syndrome Are Not Sensitive Enough to Identify MSH6 Mutation Carriers","volume":"47","author":"Sjursen","year":"2010","journal-title":"J. Med. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","article-title":"Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jnci\/djn499","article-title":"Prediction of Lynch Syndrome in Consecutive Patients with Colorectal Cancer","volume":"101","author":"Green","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2010.08.021","article-title":"The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer History","volume":"140","author":"Kastrinos","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"djv308","DOI":"10.1093\/jnci\/djv308","article-title":"Comparison of Prediction Models for Lynch Syndrome Among Individuals with Colorectal Cancer","volume":"108","author":"Kastrinos","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","article-title":"Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population","volume":"4","author":"Dinh","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_78","unstructured":"NICE (2017). Molecular Testing Strategies for Lynch Syndrome in People with Colorectal Cancer Diagnostics Guidance, The National Institute for Health and Care Excellence."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability","volume":"96","author":"Umar","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New Clinical Criteria for Hereditary Nonpolyposis Colorectal Cancer (HNPCC, Lynch Syndrome) Proposed by the International Collaborative Group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2012.13088","article-title":"Identification of Lynch Syndrome Among Patients with Colorectal Cancer","volume":"308","author":"Moreira","year":"2012","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Stewart, A. (2013). Genetic Testing Strategies in Newly Diagnosed Endometrial Cancer Patients Aimed at Reducing Morbidity or Mortality from Lynch Syndrome in the Index Case or Her Relatives. PLoS Curr., 5.","DOI":"10.1371\/currents.eogt.b59a6e84f27c536e50db4e46aa26309c"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/bjs.11902","article-title":"European Guidelines from the EHTG and ESCP for Lynch Syndrome: An Updated Third Edition of the Mallorca Guidelines Based on Gene and Gender","volume":"108","author":"Latchford","year":"2021","journal-title":"Br. J. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/clinchem\/45.5.732","article-title":"Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing","volume":"45","author":"Holtzman","year":"1999","journal-title":"Clin. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"(1996). Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility, Adopted on February 20, 1996. J. Clin. Oncol., 14, 1730\u20131736.","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7861\/clinmed.2022-0372","article-title":"Mainstreaming of Genomics in Oncology: A Nationwide Survey of the Genomics Training Needs of UK Oncologists","volume":"23","author":"Tutika","year":"2023","journal-title":"Clin. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.23922\/jarc.2017-028","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)","volume":"2","author":"Ishida","year":"2018","journal-title":"J. Anus Rectum Colon"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0042-121005","article-title":"Virtual Chromoendoscopy (I-SCAN) Detects More Polyps in Patients with Lynch Syndrome: A Randomized Controlled Crossover Trial","volume":"49","author":"Bisschops","year":"2017","journal-title":"Endoscopy"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2018.07.030","article-title":"No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies","volume":"155","author":"Engel","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cgh.2020.11.002","article-title":"Quality of Colonoscopy Is Associated with Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome","volume":"20","author":"Roos","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.gie.2014.10.014","article-title":"Guidelines on Genetic Evaluation and Management of Lynch Syndrome","volume":"81","author":"Dinjens","year":"2015","journal-title":"Gastrointest. Endosc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0028-1119628","article-title":"Chromocolonoscopy Detects More Adenomas than White Light Colonoscopy or Narrow Band Imaging Colonoscopy in Hereditary Nonpolyposis Colorectal Cancer Screening","volume":"41","author":"Lammert","year":"2009","journal-title":"Endoscopy"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ajg.2014.423","article-title":"Impact of Chromoscopy on Adenoma Detection in Patients with Lynch Syndrome: A Prospective, Multicenter, Blinded, Tandem Colonoscopy Study","volume":"110","author":"Rahmi","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1542-3565(05)00403-9","article-title":"Chromoendoscopic Colonoscopy for Detecting Preneoplastic Lesions in Hereditary Nonpolyposis Colorectal Cancer Syndrome","volume":"3","author":"Lecomte","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1572-0241.2005.41481.x","article-title":"The Role of High-Magnification-Chromoscopic Colonoscopy in Hereditary Nonpolyposis Colorectal Cancer Screening: A Prospective \u201cBack-to-Back\u201d Endoscopic Study","volume":"100","author":"Hurlstone","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gutjnl-2020-323132","article-title":"Linked Colour Imaging for the Detection of Polyps in Patients with Lynch Syndrome: A Multicentre, Parallel Randomised Controlled Trial","volume":"71","author":"Houwen","year":"2022","journal-title":"Gut"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2019.04.227","article-title":"Effect of Chromoendoscopy in the Proximal Colon on Colorectal Neoplasia Detection in Lynch Syndrome: A Multicenter Randomized Controlled Trial","volume":"90","author":"Haanstra","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/j.gastro.2019.09.003","article-title":"White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study","volume":"158","author":"Herrero","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gie.2020.06.059","article-title":"Performance of Artificial Intelligence in Colonoscopy for Adenoma and Polyp Detection: A Systematic Review and Meta-Analysis","volume":"93","author":"Hassan","year":"2021","journal-title":"Gastrointest. Endosc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2468-1253(19)30411-X","article-title":"Effect of a Deep-Learning Computer-Aided Detection System on Adenoma Detection during Colonoscopy (CADe-DB Trial): A Double-Blind Randomised Study","volume":"5","author":"Wang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2020.04.062","article-title":"Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial","volume":"159","author":"Repici","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/gutjnl-2021-324471","article-title":"Artificial Intelligence and Colonoscopy Experience: Lessons from Two Randomised Trials","volume":"71","author":"Repici","year":"2022","journal-title":"Gut"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ueg2.12354","article-title":"Real-time Use of Artificial Intelligence (CADEYE) in Colorectal Cancer Surveillance of Patients with Lynch Syndrome\u2014A Randomized Controlled Pilot Trial (CADLY)","volume":"11","author":"Bucksch","year":"2023","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.gie.2022.02.009","article-title":"Artificial Intelligence\u2013Assisted Detection of Colorectal Polyps in Lynch Syndrome","volume":"95","author":"Tanabe","year":"2022","journal-title":"Gastrointest. Endosc."},{"key":"ref_106","unstructured":"Gupta, S., Weiss, J.M., Burke, C.A., Chung, D.C., Clayback, K.M., Dallas, S., Felder, S., Giardiello, F.M., Grady, W., and Hagemann, A. (2023, December 20). NCCN Guidelines Version 2.2023 Genetic\/Familial High-Risk Assessment: Colorectal Continue. Available online: https:\/\/www.nccn.org\/home\/."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","article-title":"The Immune Biology of Microsatellite-Unstable Cancer","volume":"2","author":"Kloor","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"13255","DOI":"10.1073\/pnas.231326898","article-title":"Frameshift-Mutation-Derived Peptides as Tumor-Specific Antigens in Inherited and Spontaneous Colorectal Cancer","volume":"98","author":"Lislerud","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints","volume":"5","author":"Llosa","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e1515612","DOI":"10.1080\/2162402X.2018.1515612","article-title":"Immunoprofiles of Colorectal Cancer from Lynch Syndrome","volume":"8","author":"Walkowska","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1038\/s41598-018-30466-x","article-title":"A Cancer Vaccine Approach for Personalized Treatment of Lynch Syndrome","volume":"8","author":"Majumder","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch Repair Deficiency Predicts Response of Solid Tumors to PD-1 Blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability\u2013High Advanced Colorectal Cancer","volume":"383","author":"Shiu","year":"2020","journal-title":"New Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus Chemotherapy for Microsatellite Instability-High or Mismatch Repair-Deficient Metastatic Colorectal Cancer (KEYNOTE-177): Final Analysis of a Randomised, Open-Label, Phase 3 Study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.annonc.2022.06.008","article-title":"Nivolumab plus Low-Dose Ipilimumab in Previously Treated Patients with Microsatellite Instability-High\/Mismatch Repair-Deficient Metastatic Colorectal Cancer: 4-Year Follow-up from CheckMate 142","volume":"33","author":"Lonardi","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in Patients with Metastatic DNA Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer (CheckMate 142): An Open-Label, Multicentre, Phase 2 Study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"S1389","DOI":"10.1016\/j.annonc.2022.08.016","article-title":"LBA7 Neoadjuvant Immune Checkpoint Inhibition in Locally Advanced MMR-Deficient Colon Cancer: The NICHE-2 Study","volume":"33","author":"Chalabi","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/oncolo\/oyad082","article-title":"BRAF V600E\/RAS Mutations and Lynch Syndrome in Patients With MSI-H\/DMMR Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors","volume":"28","author":"Colle","year":"2023","journal-title":"Oncologist"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41591-023-02544-9","article-title":"Neoplasia Risk in Patients with Lynch Syndrome Treated with Immune Checkpoint Blockade","volume":"29","author":"Harrold","year":"2023","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.esmoop.2020.100044","article-title":"Immune Checkpoint Inhibitor Treatment of a First Cancer Is Associated with a Decreased Incidence of Second Primary Cancer","volume":"6","author":"Heudel","year":"2021","journal-title":"ESMO Open"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1147590","DOI":"10.3389\/fonc.2023.1147590","article-title":"Lynch Syndrome Cancer Vaccines: A Roadmap for the Development of Precision Immunoprevention Strategies","volume":"13","author":"Sei","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1158\/1078-0432.CCR-19-3517","article-title":"A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I\/IIa Clinical Trial","volume":"26","author":"Kloor","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1053\/j.gastro.2021.06.073","article-title":"Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity with Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model","volume":"161","author":"Gebert","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Serrano, D., Patrignani, P., Stigliano, V., Turchetti, D., Sciallero, S., Roviello, F., D\u2019Arpino, A., Grattagliano, I., Testa, S., and Oliani, C. (2022). Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine. Genes, 13.","DOI":"10.3390\/genes13030460"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"djv170","DOI":"10.1093\/jnci\/djv170","article-title":"Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome","volume":"107","author":"Dashti","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1158\/1078-0432.CCR-20-3635","article-title":"The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer","volume":"27","author":"Arai","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Catalano, F., Borea, R., Puglisi, S., Boutros, A., Gandini, A., Cremante, M., Martelli, V., Sciallero, S., and Puccini, A. (2022). Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. Cancers, 14.","DOI":"10.3390\/cancers14061388"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.annonc.2022.07.008","article-title":"Comprehensive Cancer Predisposition Testing within the Prospective MASTER Trial Identifies Hereditary Cancer Patients and Supports Treatment Decisions for Rare Cancers","volume":"33","author":"Jahn","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamaoncol.2018.0104","article-title":"Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients with Colorectal Cancer","volume":"4","author":"Hampel","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.canep.2022.102291","article-title":"Lessons Learnt from the Implementation of a Colorectal Cancer Screening Programme for Lynch Syndrome in a Tertiary Public Hospital","volume":"82","author":"Navarro","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1016\/j.cgh.2019.10.021","article-title":"Cost-Effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases","volume":"18","author":"Peterse","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.gim.2022.05.016","article-title":"The Predicted Effect and Cost-Effectiveness of Tailoring Colonoscopic Surveillance According to Mismatch Repair Gene in Patients with Lynch Syndrome","volume":"24","author":"Kang","year":"2022","journal-title":"Genet. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/5\/849\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:53Z","timestamp":1760104913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/5\/849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":132,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cancers16050849"],"URL":"https:\/\/doi.org\/10.3390\/cancers16050849","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}